Bouby N, Hus-Citharel A, Marchetti J, Bankir L, Corvol P, Llorens-Cortes C
Institut National de la Santé et de la Recherche Médicale U 90, Paris, France.
J Am Soc Nephrol. 1997 Nov;8(11):1658-67. doi: 10.1681/ASN.V8111658.
The localization of two type 1 angiotensin II receptor subtype mRNA, AT1A and AT1B, was determined by reverse transcription-PCR on microdissected glomeruli and nephron segments. The coupling sensitivity of these two receptor subtypes was evaluated by measuring variations in intracellular calcium ([Ca2+]i) elicited by angiotensin II (Ang II) in structures expressing either AT1A or AT1B mRNA, using Fura-2 fluorescence. The highest expression of AT1 mRNA was found in glomerulus, proximal tubule, and thick ascending limb. In glomerulus, AT1A and AT1B mRNA were similarly expressed, whereas in all nephron segments AT1A mRNA expression was dominant (approximately 84%). The increase in [Ca2+]i elicited by 10(-7) mol/L Ang II was highest in proximal segments (delta [Ca2+]i is approximately equivalent to 300 to 400 nmol/L) and thick ascending limb (delta [Ca2+]i is approximately equivalent to 200 nmol/L). In glomerulus and collecting duct, the response was lower (delta < 100 nmol/L). The median effective concentrations for Ang II were of the same order of magnitude in glomerulus (12.2 nmol/L), in which both AT1A and AT1B are expressed, and in cortical thick ascending limb (10.3 nmol/ L), in which AT1A is almost exclusively expressed. The Ang II-induced calcium responses were totally abolished by the AT1 receptor antagonist losartan (1 mumol/L) but not by the AT2 antagonist PD 123319 (1 mumol/L). In the absence of external Ca2+, the peak phase of the response induced by 10(-7) mol/L Ang II was reduced and shortened, suggesting that a part of the [Ca2+]i increase originated from the mobilization of the intracellular Ca2+ pool. In conclusion, these results demonstrate that in the rat kidney: (1) AT1A is the predominant AT1 receptor subtype expressed in the nephron segments, (2) glomerulus is the only structure with a relatively high AT1B mRNA content, and (3) AT1A and AT1B receptor subtypes do not differ in their efficiency for the activation of calcium second-messenger system.
通过逆转录聚合酶链反应(RT-PCR),在显微切割的肾小球和肾单位节段上确定了两种1型血管紧张素II受体亚型mRNA,即AT1A和AT1B的定位。使用Fura-2荧光法,通过测量血管紧张素II(Ang II)在表达AT1A或AT1B mRNA的结构中引起的细胞内钙([Ca2+]i)变化,评估这两种受体亚型的偶联敏感性。AT1 mRNA在肾小球、近端小管和髓袢升支粗段中表达最高。在肾小球中,AT1A和AT1B mRNA表达相似,而在所有肾单位节段中,AT1A mRNA表达占主导(约84%)。10(-7)mol/L Ang II引起的[Ca2+]i升高在近端节段(δ[Ca2+]i约相当于300至400 nmol/L)和髓袢升支粗段(δ[Ca2+]i约相当于200 nmol/L)中最高。在肾小球和集合管中,反应较低(δ<100 nmol/L)。Ang II的半数有效浓度在同时表达AT1A和AT1B的肾小球(12.2 nmol/L)和几乎仅表达AT1A的皮质髓袢升支粗段(10.3 nmol/L)中处于同一数量级。AT1受体拮抗剂氯沙坦(1 μmol/L)可完全消除Ang II诱导的钙反应,但AT2拮抗剂PD 123319(1 μmol/L)则不能。在无细胞外Ca2+的情况下,10(-7)mol/L Ang II诱导的反应的峰值期降低且缩短,这表明[Ca2+]i升高的一部分源于细胞内钙池的动员。总之,这些结果表明,在大鼠肾脏中:(1)AT1A是在肾单位节段中表达的主要AT1受体亚型;(2)肾小球是唯一具有相对较高AT1B mRNA含量的结构;(3)AT1A和AT1B受体亚型在激活钙第二信使系统的效率上没有差异。